Search
KW-7158
go.drugbank.com/drugs/DB05498ExperimentalKW-7158 is a tricyclic compound with a non-cholingergic mechanism of action for the treatment of "urinary urgency," "frequent urination" and "urinary incontinence" associated with bladder overactivity … The therapeutic effects of KW-7158 in overactive bladder may be due to the activation of A-type K(+) channels which regulate afferent neuron excitability and firing properties in the dorsal root ganglion
Obinepitide
go.drugbank.com/drugs/DB05045ExperimentalObinepitide is a synthetic analogue of two natural human hormones, PYY and Pancreatic Polypeptide, which normally are released during a meal. … In obinepitide, the properties of both of these hormones have been implanted into a single molecule.
Synonyms: (34-L-glutamine)pancreatic hormone (human)AVI-5126
go.drugbank.com/drugs/DB05726InvestigationalAVI-526 works by silencing a gene known as c-myc, a key regulatory gene involved in cardiovascular restenosis. … AVI-526 is an improved formulation of [AVI-4557], developed for use on Vein Grafts before use in Heart by-Pass Graft Surgery.
Dimethylaminopropionylphenothiazine
go.drugbank.com/drugs/DB13672ExperimentalCategories: Drugs for Functional Gastrointestinal DisordersNicofetamide
go.drugbank.com/drugs/DB13531ExperimentalCategories: Drugs for Functional Gastrointestinal DisordersPocenbrodib
go.drugbank.com/drugs/DB21616InvestigationalPocenbrodib has a monoisotopic molecular weight of 525.23 Da. … Pocenbrodib is a small molecule drug.
TM30339
go.drugbank.com/drugs/DB05085ExperimentalTM30339 thus imitates a natural mechanism, a satiety signal from the gastrointestinal system involved in the regulation of food intake in humans. TM30339 is developed for the treatment of obesity.
Cefacetrile
go.drugbank.com/drugs/DB01414InvestigationalVet approvedA derivative of 7-aminocephalosporanic acid.
Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseSurotomycin
go.drugbank.com/drugs/DB12076InvestigationalSurotomycin is non-inferior to vancomycin and offers a promising alternative for the treatment and prevention of C. diff infection. … It is a benzenebutanoic acid derivative patented by Cubist Pharmaceuticals, Inc. as antibacterial agents for the treatment of Gram-positive infections.